INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 206S206 trades$1.10M
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$22.46M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,770 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Tax withholding
F$331K
1,438 sh
Dec 20, 2025Dec 23, 2025
Page 1576 of 1820
← PrevNext →
traded Dec 20, 2025
+3d
SEC Form 4

Evidence

15
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$359K
5,281 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

15
LC
Llewellyn Lindsay CatherineSEE REMARKS
LYFTLyft, Inc.
Tax withholding
F$619K
31.9K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

15
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$26K
50 sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

15
RV
Raghunathan VivekSVP, Engineering and Support
SNOWSnowflake Inc.
Tax withholding
F$805K
3,617 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

15
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Tax withholding
F$381K
1,652 sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

15
CJ
Cumello JosephSVP, General Mgr. Blue Planet
CIENCIENA CORP
Tax withholding
F$257K
1,117 sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

15
SA
Singh AjayChief Product Officer
PSTGEverpure, Inc.
Tax withholding
F$487K
7,038 sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

15
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Tax withholding
F$255K
1,109 sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$36K
5,582 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$29K
4,367 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

14
MM
Markovich John M.Chief Financial Officer
QBTSD-Wave Quantum Inc.
Option exercise · 10b5-1 plan
M$92K
100.0K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

14
Risher John DavidDirector, Chief Executive Officer
LYFTLyft, Inc.
Tax withholding
F$6.37M
328.0K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Option exercise
M—
13.1K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Option exercise
M—
23.3K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
KA
Kelly Patrick ArthurCo-President and COO
CIFRCipher Digital Inc.
Option exercise
M—
305.7K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
PA
Paradise AndrewDirector, Chief Executive Officer, 10% Owner
SKLZFiry Inc.
Option exercise
M—
71.4K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

13
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Option exercise
M—
14.0K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
HK
Haynes Larry KDirector
CACCAMDEN NATIONAL CORP
Grant or award
A$14K
312 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
WK
Wakeford KentDirector
SKLZFiry Inc.
Option exercise
M—
304 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

13
KE
Kargieman EmilianoDirector, Chief Executive Officer, 10% Owner
SATLSatellogic Inc.
Option exercise
M—
26.5K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
IW
Iwaschuk WilliamCo-President and CLO
CIFRCipher Digital Inc.
Option exercise
M—
305.7K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
MR
Maxwell RainaDirector
CACCAMDEN NATIONAL CORP
Grant or award
A$14K
312 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Option exercise
M—
13.0K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

13
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion
C—
100.0K sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

13
RL
Ropiecki Gary LloydPrincipal Accounting Officer
UVEUNIVERSAL INSURANCE HOLDINGS, INC.
Tax withholding
F$14K
406 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
RT
Rosen TamiDirector, Chief Development Officer
PGYPagaya Technologies Ltd.
Open-market sale · 10b5-1 plan
SELL$232K
7,561 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$168K
9,200 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

13
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Option exercise
M—
23.3K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Option exercise
M—
9,237 sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
ZN
Zojwalla NaseemChief Medical Officer
OLMAOlema Pharmaceuticals, Inc.
Option exercise
M—
50.0K sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

13
PT
Page TylerDirector, Chief Executive Officer
CIFRCipher Digital Inc.
Option exercise
M—
1.02M sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
KR
Kumar RakhiDirector
NPCENeuroPace Inc
Grant or award
A$15K
904 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence

13
BE
Baratz Alan EDirector, President & CEO
QBTSD-Wave Quantum Inc.
Option exercise · 10b5-1 plan
M$722K
793.7K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

13
DR
Dunn RickChief Financial Officer
SATLSatellogic Inc.
Option exercise
M—
10.6K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

13
TM
Tirman MatthewPresident
SATLSatellogic Inc.
Option exercise
M—
10.6K sh
Dec 20, 2025Dec 23, 2025
traded Dec 20, 2025
+3dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

12
DD
DeSantis Dean10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
120.0K sh
Dec 23, 2025Dec 23, 2025
traded Dec 23, 2025
+0dSEC Form 4

Evidence

12
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$318K
9,701 sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC Form 4

Evidence

12
MH
Milmoe William H.10% Owner
CELHCelsius Holdings, Inc.
Other acquisition or disposition
J—
115.4K sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC Form 4

Evidence